Affimed N.V.

General ticker "AFMD" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $44.3M (TTM average)

Affimed N.V. does not follow the US Stock Market performance with the rate: -11.4%.

Estimated limits based on current volatility of 17.3%: low 0.06$, high 0.08$

Factors to consider:

  • Earnings for 12 months up through Q4 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.34$, 6.93$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.03$, 8.08$]

Financial Metrics affecting the AFMD estimates:

  • Negative: Non-GAAP EPS, $ of -7.55 <= 0.04
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -65.49 <= 1.76
  • Negative: Industry earnings per price (median), % of -30.69 <= 0
  • Negative: negative Operating income
  • Positive: Interest expense per share, $ of 0.13 <= 0.67
  • Negative: Inventory ratio change, % of 15.40 > 1.03
  • Negative: Industry operating cash flow per share per price (median), % of -25.05 <= 2.83
  • Negative: negative Industry operating income (median)
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: -3.17 < Investing cash flow per share, $ of -2.66

Similar symbols

Short-term AFMD quotes

Long-term AFMD plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue €40.37MM €41.35MM €8.28MM
Operating Expenses €104.40MM €129.47MM €114.94MM
Operating Income €-64.03MM €-88.12MM €-106.66MM
Non-Operating Income €6.51MM €2.12MM €0.73MM
Interest Expense €0.71MM €1.63MM €1.81MM
R&D Expense €81.49MM €98.81MM €94.96MM
Income(Loss) €-57.52MM €-86.00MM €-105.94MM
Taxes €0.00MM €0.00MM €0.00MM
Profit(Loss)* €-57.52MM €-86.00MM €-105.94MM
Stockholders Equity €135.95MM €152.91MM €57.81MM
Inventory €0.42MM €0.63MM €0.46MM
Assets €225.13MM €200.51MM €97.16MM
Operating Cash Flow €-86.59MM €-104.89MM €-110.27MM
Capital expenditure €3.85MM €0.70MM €3.73MM
Investing Cash Flow €-3.85MM €5.61MM €-36.06MM
Financing Cash Flow €133.58MM €88.56MM €-6.22MM
Earnings Per Share** €-4.81 €-6.04 €-7.09

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.